Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
10.21
+0.29 (2.92%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.54 billion as of March 9, 2026. Its market cap has decreased by -58.85% in one year.
Market Cap
1.54B
Enterprise Value
1.50B
1-Year Change
-58.85%
Ranking
Category
Stock Price
$10.21
Market Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $1.54B, an increase of 487.11%. That is a compound annual growth rate of 66.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.54B | 2.52% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intellia Therapeutics | 1.59B |
| Nuvation Bio | 1.57B |
| Nurix Therapeutics | 1.55B |
| Kodiak Sciences | 1.54B |
| Vir Biotechnology | 1.53B |
| Ardelyx | 1.52B |
| Capricor Therapeutics | 1.44B |
| Rapport Therapeutics | 1.44B |